cyclo(tyrosyl-tyrosyl) has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Carvalho, LPS; Gomaa, MS; Helal, MA; Kishk, SM; McLean, KJ; Mostafa, SM; Munro, AW; Salama, I; Simons, C; Sood, S | 1 |
| Abell, C; Blankley, RT; Campbell, B; Charoensutthivarakul, S; Coyne, AG; de Carvalho, LPS; Evangelopoulos, D; Frederickson, M; Katariya, MM; Kavanagh, ME; Levy, CW; Leys, D; McLean, KJ; Munro, AW; Selvam, IR; Tunnicliffe, RB | 1 |
2 other study(ies) available for cyclo(tyrosyl-tyrosyl) and Koch's Disease
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
Topics: Antitubercular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipeptides; Drug Design; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Peptides, Cyclic; Piperazines; Tuberculosis | 2019 |
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
Topics: Antitubercular Agents; Drug Design; Humans; Mycobacterium tuberculosis; Tuberculosis; X-Rays | 2022 |